Market revenue in 2024 | USD 29.7 million |
Market revenue in 2030 | USD 95.1 million |
Growth rate | 21.4% (CAGR from 2024 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, NGS Commercial Software |
Key market players worldwide | Bio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next-generation sequencing data analysis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 54.21% in 2024. Horizon Databook has segmented the France next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.
The decreasing cost of sequencing is estimated to accelerate the adoption of NGS technologies for research and as well as clinical applications. The French government is implementing certain projects associated with genome technologies with the aim of enhancing diagnostic developments.
AURAGEN is currently working as part of French national plan for Genomic Science. On the other hand, major players such as Eurofins French and Illumina have expanded their offerings in France. For instance, in July 2020, Illumina acquired Enancio, a French startup that designs genomic-specific compression software.
In addition, in October 2021, Patho Quest, a notable player in NGS, was granted almost USD 98 million (EUR 0.85 million) from French Investment Program for the Future. Such financial support may help Patho Quest strengthen its services with NGS-based quality control tests for a GMP-grade genetic characterization of biologics.
Horizon Databook provides a detailed overview of country-level data and insights on the France next-generation sequencing data analysis market , including forecasts for subscribers. This country databook contains high-level insights into France next-generation sequencing data analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account